Health
Combined point-of-care nucleic acid and antibody testing increases COVID-19 detection – News-Medical.Net
A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this approach was superior to virus detection alone for diagnosing…
Reviewed by Emily Henderson, B.Sc.Sep 2 2020
A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease.
Point-of-care testing – in other words, testing patients as soon as they arrive at the hospital – is essential for enabling healthcare workers to rapidly diagnose patients and…
-
Noosa News21 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
Noosa News20 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
Noosa News19 hours agoMissing man, Maroochydore – Queensland Police News
-
General23 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out